Olathe-based Metactive lands $1.5M, two medical patents
March 21, 2017 | Meghan LeVota
Olathe-based medical device company Metactive released a pair of positive announcements for the firm.
Dr. Nick Franano
In addition to being awarded two patents, the firm closed on a $1.5 million Series A funding round — bringing its total raised to over $9 million. The round was co-led by the Mid-America Angels and an unnamed investor. Previously, the firm has engaged in partnerships with the Kansas Bioscience Authority and the National Institutes of Health.
Metactive Medical focuses on the creation of embolization devices that fights cancer. It’s latest, the Blockstent Microcatheter for embolization of peripheral arteries and veins and the Ballstent Microcatheter for embolization of cerebral aneurysms, are now patented.
CEO Nick Franano said that the issuance of these patents gives Metactive exclusive rights in the U.S. and international market. He added that the capital will help accelerate the firm.
“This new funding provides Metactive with the resources to continue the development and testing of its novel embolization devices,” Franano said in a release. “Our preclinical study results show that both devices routinely provide immediate, complete, and durable occlusion, something that market leading coils, flow diverting stents, and mesh vascular plugs can’t deliver. We look forward to a time when standing in the interventional suite wearing heavy lead protective garments, placing multiple devices, and performing serial angiography waiting for a vessel to occlude will no longer be required to complete an embolization procedure.”
Embolization is a treatment that blocks the flow of blood in specific segments of arteries and veins, enabling doctors to divert blood away from cancerous tumors and other abnormal tissues. More than 150,000 peripheral vascular embolization procedures are performed each year around the world using coils and vascular plugs, which can be difficult to use and often result in incomplete treatment.
Franano is also the CEO of Flow Forward Medical, which recently raised $1 million for its vascular health device.
2017 Startups to Watch
stats here
Related Posts on Startland News
This AI keyboard can write your next email with the push of just one button; its creator says it could revolutionize workplaces
Hardware — not just software — should be at the forefront of the AI’s future, Jerry Hsu shared. After the successful release of its GPT-powered AI mouse, Jethro V1, in late 2024, Overland Park-based Virtusx — which is revolutionizing workplaces through integrating hardware and software to make AI-driving products more accessible and user-friendly — has…
Alexa, show me the winners: Storytailor leads Pure Pitch Rally prize tally ahead of tech launch
Storytailor’s marquee Pure Pitch Rally win comes at the perfect time for the Kansas City startup, its founders said. They’re preparing to roll out a new immersive storytelling platform through a partnership with Amazon’s Alexa+ next year — a move expected to bring their tech to more than 200 million Prime users. “It’s the most…
LISTEN: How the Midwest opened this German agtech company’s eyes to opportunity in the US
On this episode of our 12-part Plug and Play Topeka podcast series, we connect with Débora Moretti, co-CEO of NutriSen — a Berlin-based agtech startup building real-time molecular sensors to measure nutrient concentrations in plants directly on the field. Moretti shares how her team, alongside co-founder Tobias Vöpel, is merging biosensor technology, data-driven insights and…
Crossing lanes: KC Streetcar collaborators back aboard for expansion, dropping new merch, anthem
Opening the extended KC Streetcar line Friday completes a loop for creatives whose collaborations with the popular public transit system first emerged nearly a decade ago along Main Street — a time when Kansas City’s surging vibrancy helped curb streetcar doubters. “For us, it’s always been about representing Kansas City — the people, the culture,…